How To Write Covered Calls - An Ongoing Real Case Study! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : How To Write Covered Calls - An Ongoing Real Case Study!

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: KELLIS who wrote (1873)	4/25/1997 9:57:00 AM
From: sailor	of 14162

Kellis Having worked for and traded in companies seeking FDA approval-it is a double edged sword. Sometimes companies are so sure they are going to be approved they spend tons of money on equipment, tooling, even hiring people only to find out the FDA did NOT approve. I have seen stock in companies like this drop to 15% of value (I know the hard way). I only trade with companies who have multiple FDA projects all in final stages of approval. (Usually larger companies) Made about 4K in '97 in such companies-none have gotten FDA approval yet. CEPH may be a better company to buy and sell options on. Hate to see you end up with a few thousand shares of stock worth only 25% what you paid for them. Jim

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next